{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:22:20Z","timestamp":1786980140483,"version":"build-2736575974"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s00415-024-12866-4","type":"journal-article","created":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T08:37:29Z","timestamp":1736930249000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Anatomy-driven segmentation of parafoveal optical coherence tomography (OCT) measures may improve associations with clinical outcomes in multiple sclerosis"],"prefix":"10.1007","volume":"272","author":[{"given":"Omid","family":"Mirmosayyeb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"Weinstock-Guttman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Zivadinov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7114-4958","authenticated-orcid":false,"given":"Dejan","family":"Jakimovski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,15]]},"reference":[{"issue":"10422","key":"12866_CR1","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0140-6736(23)01473-3","volume":"403","author":"D Jakimovski","year":"2024","unstructured":"Jakimovski D, Bittner S, Zivadinov R, Morrow SA, Benedict RH, Zipp F et al (2024) Multiple sclerosis. Lancet 403(10422):183\u2013202","journal-title":"Lancet"},{"issue":"6","key":"12866_CR2","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1177\/1352458519872751","volume":"26","author":"J Lambe","year":"2020","unstructured":"Lambe J, Saidha S, Bermel RA (2020) Optical coherence tomography and multiple sclerosis: update on clinical application and role in clinical trials. Mult Scler 26(6):624\u2013639","journal-title":"Mult Scler"},{"issue":"3","key":"12866_CR3","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S1474-4422(18)30443-5","volume":"18","author":"Collaborators GBDMS","year":"2019","unstructured":"Collaborators GBDMS (2019) Global, regional, and national burden of multiple sclerosis 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 18(3):269\u2013285","journal-title":"Lancet Neurol"},{"issue":"2","key":"12866_CR4","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000665","volume":"7","author":"M Pawlitzki","year":"2020","unstructured":"Pawlitzki M, Horbrugger M, Loewe K, Kaufmann J, Opfer R, Wagner M et al (2020) MS optic neuritis-induced long-term structural changes within the visual pathway. Neurol Neuroimmunol Neuroinflamm 7(2):e665","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"8","key":"12866_CR5","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.1007\/s00415-023-11709-y","volume":"270","author":"R Ganapathy Subramanian","year":"2023","unstructured":"Ganapathy Subramanian R, Zivadinov R, Bergsland N, Dwyer MG, Weinstock-Guttman B, Jakimovski D (2023) Multiple sclerosis optic neuritis and trans-synaptic pathology on cortical thinning in people with multiple sclerosis. J Neurol 270(8):3758\u20133769","journal-title":"J Neurol"},{"issue":"1","key":"12866_CR6","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/14737175.2019.1559051","volume":"19","author":"FC Oertel","year":"2019","unstructured":"Oertel FC, Zimmermann HG, Brandt AU, Paul F (2019) Novel uses of retinal imaging with optical coherence tomography in multiple sclerosis. Expert Rev Neurother 19(1):31\u201343","journal-title":"Expert Rev Neurother"},{"key":"12866_CR7","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2023.120847","volume":"454","author":"O Mirmosayyeb","year":"2023","unstructured":"Mirmosayyeb O, Yazdan Panah M, Mokary Y, Ghaffary EM, Ghoshouni H, Zivadinov R et al (2023) Optical coherence tomography (OCT) measurements and disability in multiple sclerosis (MS): a systematic review and meta-analysis. J Neurol Sci 454:120847","journal-title":"J Neurol Sci"},{"issue":"3","key":"12866_CR8","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1007\/s00415-022-11449-5","volume":"270","author":"O Mirmosayyeb","year":"2023","unstructured":"Mirmosayyeb O, Zivadinov R, Weinstock-Guttman B, Benedict RHB, Jakimovski D (2023) Optical coherence tomography (OCT) measurements and cognitive performance in multiple sclerosis: a systematic review and meta-analysis. J Neurol 270(3):1266\u20131285","journal-title":"J Neurol"},{"issue":"10","key":"12866_CR9","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S1474-4422(17)30278-8","volume":"16","author":"A Petzold","year":"2017","unstructured":"Petzold A, Balcer LJ, Calabresi PA, Costello F, Frohman TC, Frohman EM et al (2017) Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis. Lancet Neurol 16(10):797\u2013812","journal-title":"Lancet Neurol"},{"key":"12866_CR10","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2021.117552","volume":"427","author":"D Jakimovski","year":"2021","unstructured":"Jakimovski D, Zivadinov R, Vaughn CB, Ozel O, Weinstock-Guttman B (2021) Clinical effects associated with five-year retinal nerve fiber layer thinning in multiple sclerosis. J Neurol Sci 427:117552","journal-title":"J Neurol Sci"},{"issue":"9","key":"12866_CR11","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1093\/brain\/awq146","volume":"133","author":"AP Henderson","year":"2010","unstructured":"Henderson AP, Altmann DR, Trip AS, Kallis C, Jones SJ, Schlottmann PG et al (2010) A serial study of retinal changes following optic neuritis with sample size estimates for acute neuroprotection trials. Brain 133(9):2592\u20132602","journal-title":"Brain"},{"issue":"9","key":"12866_CR12","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1007\/s00415-017-8531-y","volume":"264","author":"J Britze","year":"2017","unstructured":"Britze J, Pihl-Jensen G, Frederiksen JL (2017) Retinal ganglion cell analysis in multiple sclerosis and optic neuritis: a systematic review and meta-analysis. J Neurol 264(9):1837\u20131853","journal-title":"J Neurol"},{"issue":"5","key":"12866_CR13","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1177\/1352458520935724","volume":"27","author":"G Bsteh","year":"2021","unstructured":"Bsteh G, Berek K, Hegen H, Altmann P, Wurth S, Auer M et al (2021) Macular ganglion cell-inner plexiform layer thinning as a biomarker of disability progression in relapsing multiple sclerosis. Mult Scler 27(5):684\u2013694","journal-title":"Mult Scler"},{"issue":"11","key":"12866_CR14","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S1474-4422(12)70213-2","volume":"11","author":"S Saidha","year":"2012","unstructured":"Saidha S, Sotirchos ES, Ibrahim MA, Crainiceanu CM, Gelfand JM, Sepah YJ et al (2012) Microcystic macular oedema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: a retrospective study. Lancet Neurol 11(11):963\u2013972","journal-title":"Lancet Neurol"},{"issue":"3","key":"12866_CR15","first-page":"205521731987158","volume":"5","author":"LJ Balk","year":"2019","unstructured":"Balk LJ, Coric D, Knier B, Zimmermann HG, Behbehani R, Alroughani R et al (2019) Retinal inner nuclear layer volume reflects inflammatory disease activity in multiple sclerosis; a longitudinal OCT study. Mult Scler J Exp Transl Clin 5(3):2055217319871582","journal-title":"Mult Scler J Exp Transl Clin"},{"issue":"5","key":"12866_CR16","doi-asserted-by":"crossref","first-page":"e596","DOI":"10.1212\/NXI.0000000000000596","volume":"6","author":"M Cellerino","year":"2019","unstructured":"Cellerino M, Cordano C, Boffa G, Bommarito G, Petracca M, Sbragia E et al (2019) Relationship between retinal inner nuclear layer, age, and disease activity in progressive MS. Neurol Neuroimmunol Neuroinflamm 6(5):e596","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"12866_CR17","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2147\/EB.S295610","volume":"13","author":"N Schurz","year":"2021","unstructured":"Schurz N, Sariaslani L, Altmann P, Leutmezer F, Mitsch C, Pemp B et al (2021) Evaluation of retinal layer thickness parameters as biomarkers in a real-world multiple sclerosis cohort. Eye Brain 13:59\u201369","journal-title":"Eye Brain"},{"key":"12866_CR18","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/605940","author":"DS Ng","year":"2015","unstructured":"Ng DS, Gupta P, Tham YC, Peck CF, Wong TY, Ikram MK et al (2015) Repeatability of perimacular ganglion cell complex analysis with spectral-domain optical coherence tomography. J Ophthalmol. https:\/\/doi.org\/10.1155\/2015\/605940","journal-title":"J Ophthalmol"},{"issue":"13","key":"12866_CR19","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1177\/1352458519881428","volume":"26","author":"D Jakimovski","year":"2020","unstructured":"Jakimovski D, Zivadinov R, Ramanthan M, Hagemeier J, Weinstock-Guttman B, Tomic D et al (2020) Serum neurofilament light chain level associations with clinical and cognitive performance in multiple sclerosis: a longitudinal retrospective 5-year study. Mult Scler J 26(13):1670\u20131681","journal-title":"Mult Scler J"},{"issue":"2","key":"12866_CR20","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","volume":"17","author":"AJ Thompson","year":"2018","unstructured":"Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G et al (2018) Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 17(2):162\u2013173","journal-title":"Lancet Neurol"},{"issue":"11","key":"12866_CR21","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","volume":"33","author":"JF Kurtzke","year":"1983","unstructured":"Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33(11):1444\u20131452","journal-title":"Neurology"},{"issue":"7","key":"12866_CR22","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1212\/01.WNL.0000156155.19270.F8","volume":"64","author":"R Roxburgh","year":"2005","unstructured":"Roxburgh R, Seaman S, Masterman T, Hensiek A, Sawcer S, Vukusic S et al (2005) Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity. Neurology 64(7):1144\u20131151","journal-title":"Neurology"},{"issue":"3","key":"12866_CR23","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1212\/WNL.0000000000000560","volume":"83","author":"FD Lublin","year":"2014","unstructured":"Lublin FD, Reingold SC, Cohen JA, Cutter GR, S\u00f8rensen PS, Thompson AJ et al (2014) Defining the clinical course of multiple sclerosis: the 2013 revisions. Neurology 83(3):278\u2013286","journal-title":"Neurology"},{"issue":"1","key":"12866_CR24","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/ene.13769","volume":"26","author":"D Jakimovski","year":"2019","unstructured":"Jakimovski D, Gandhi S, Paunkoski I, Bergsland N, Hagemeier J, Ramasamy D et al (2019) Hypertension and heart disease are associated with development of brain atrophy in multiple sclerosis: a 5-year longitudinal study. Eur J Neurol 26(1):87-e8","journal-title":"Eur J Neurol"},{"issue":"3","key":"12866_CR25","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1177\/1352458519828667","volume":"26","author":"D Jakimovski","year":"2020","unstructured":"Jakimovski D, Ramanathan M, Weinstock-Guttman B, Bergsland N, Ramasamay DP, Carl E et al (2020) Higher EBV response is associated with more severe gray matter and lesion pathology in relapsing multiple sclerosis patients: a case-controlled magnetization transfer ratio study. Mult Scler J 26(3):322\u201332","journal-title":"Mult Scler J"},{"issue":"24","key":"12866_CR26","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1212\/WNL.0000000000002774","volume":"86","author":"A Cruz-Herranz","year":"2016","unstructured":"Cruz-Herranz A, Balk LJ, Oberwahrenbrock T, Saidha S, Martinez-Lapiscina EH, Lagreze WA et al (2016) The APOSTEL recommendations for reporting quantitative optical coherence tomography studies. Neurology 86(24):2303\u20139","journal-title":"Neurology"},{"issue":"2","key":"12866_CR27","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1177\/1352458514538110","volume":"21","author":"S Schippling","year":"2015","unstructured":"Schippling S, Balk L, Costello F, Albrecht P, Balcer L, Calabresi P et al (2015) Quality control for retinal OCT in multiple sclerosis: validation of the OSCAR-IB criteria. Mult Scler J 21(2):163\u201370","journal-title":"Mult Scler J"},{"issue":"4","key":"12866_CR28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0034823","volume":"7","author":"P Tewarie","year":"2012","unstructured":"Tewarie P, Balk L, Costello F, Green A, Martin R, Schippling S et al (2012) The OSCAR-IB consensus criteria for retinal OCT quality assessment. PLoS ONE 7(4):e34823","journal-title":"PLoS ONE"},{"issue":"1","key":"12866_CR29","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/cne.903000103","volume":"300","author":"CA Curcio","year":"1990","unstructured":"Curcio CA, Allen KA (1990) Topography of ganglion cells in human retina. J Comparative Neurol 300(1):5\u201325","journal-title":"J Comparative Neurol"},{"issue":"1","key":"12866_CR30","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1177\/1352458517740214","volume":"25","author":"AM Pietroboni","year":"2019","unstructured":"Pietroboni AM, Dell\u2019Arti L, Caprioli M, Scarioni M, Carandini T, Arighi A et al (2019) The loss of macular ganglion cells begins from the early stages of disease and correlates with brain atrophy in multiple sclerosis patients. Mult Scler 25(1):31\u20138","journal-title":"Mult Scler"},{"key":"12866_CR31","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.msard.2018.02.010","volume":"21","author":"R Behbehani","year":"2018","unstructured":"Behbehani R, Adnan H, Al-Hassan AA, Al-Salahat A, Alroughani R (2018) Predictors of retinal atrophy in multiple sclerosis: a longitudinal study using spectral domain optical coherence tomography with segmentation analysis. Mult Scler Relat Disord 21:56\u201362","journal-title":"Mult Scler Relat Disord"},{"issue":"12","key":"12866_CR32","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1016\/j.ophtha.2014.06.047","volume":"121","author":"C Zhang","year":"2014","unstructured":"Zhang C, Tatham AJ, Weinreb RN, Zangwill LM, Yang Z, Zhang JZ et al (2014) Relationship between ganglion cell layer thickness and estimated retinal ganglion cell counts in the glaucomatous macula. Ophthalmology 121(12):2371\u20139","journal-title":"Ophthalmology"},{"issue":"9","key":"12866_CR33","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1002\/mds.27728","volume":"34","author":"A Murueta-Goyena","year":"2019","unstructured":"Murueta-Goyena A, Del Pino R, Reyero P, Gald\u00f3s M, Arana B, Lucas-Jim\u00e9nez O et al (2019) Parafoveal thinning of inner retina is associated with visual dysfunction in Lewy body diseases. Mov Disord 34(9):1315\u201324","journal-title":"Mov Disord"},{"issue":"6","key":"12866_CR34","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1001\/archophthalmol.2009.106","volume":"127","author":"ME Hajee","year":"2009","unstructured":"Hajee ME, March WF, Lazzaro DR, Wolintz AH, Shrier EM, Glazman S et al (2009) Inner retinal layer thinning in Parkinson disease. Arch Ophthalmol 127(6):737\u201341","journal-title":"Arch Ophthalmol"},{"issue":"5","key":"12866_CR35","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1177\/1533317515628053","volume":"31","author":"JA Pillai","year":"2016","unstructured":"Pillai JA, Bermel R, Bonner-Jackson A, Rae-Grant A, Fernandez H, Bena J et al (2016) Retinal nerve fiber layer thinning in Alzheimer\u2019s disease: a case-control study in comparison to normal aging, Parkinson\u2019s disease, and non-Alzheimer\u2019s dementia. Am J Alzheimers Dis Other Demen 31(5):430\u20136","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"12866_CR36","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.parkreldis.2018.06.016","volume":"56","author":"J Matlach","year":"2018","unstructured":"Matlach J, Wagner M, Malzahn U, Schmidtmann I, Steigerwald F, Musacchio T et al (2018) Retinal changes in Parkinson\u2019s disease and glaucoma. Parkinsonism Relat Disord 56:41\u20136","journal-title":"Parkinsonism Relat Disord"},{"issue":"2","key":"12866_CR37","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.ophtha.2013.09.035","volume":"121","author":"E Garcia-Martin","year":"2014","unstructured":"Garcia-Martin E, Polo V, Larrosa JM, Marques ML, Herrero R, Martin J et al (2014) Retinal layer segmentation in patients with multiple sclerosis using spectral domain optical coherence tomography. Ophthalmology 121(2):573\u20139","journal-title":"Ophthalmology"},{"issue":"10","key":"12866_CR38","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1136\/bjophthalmol-2014-306538","volume":"99","author":"S Kim","year":"2015","unstructured":"Kim S, Lee JY, Kim SO, Kook MS (2015) Macular structure-function relationship at various spatial locations in glaucoma. Br J Ophthalmol 99(10):1412\u20138","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"12866_CR39","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/IJG.0b013e31816f75e9","volume":"18","author":"H Jampel","year":"2009","unstructured":"Jampel H, Vitale S, Ding Y, Knezevich F 3rd, Quigley H, Zeimer R (2009) Retinal thickness in eyes of older normal individuals and its implication for the diagnosis of glaucoma. J Glaucoma 18(1):37\u201343","journal-title":"J Glaucoma"},{"issue":"1","key":"12866_CR40","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/ana.24548","volume":"79","author":"C La Morgia","year":"2016","unstructured":"La Morgia C, Ross-Cisneros FN, Koronyo Y, Hannibal J, Gallassi R, Cantalupo G et al (2016) Melanopsin retinal ganglion cell loss in Alzheimer disease. Ann Neurol 79(1):90\u2013109","journal-title":"Ann Neurol"},{"issue":"5","key":"12866_CR41","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1001\/jamaneurol.2016.5131","volume":"74","author":"E Meltzer","year":"2017","unstructured":"Meltzer E, Sguigna PV, Subei A, Beh S, Kildebeck E, Conger D et al (2017) Retinal architecture and melanopsin-mediated pupillary response characteristics: a putative pathophysiologic signature for the retino-hypothalamic tract in multiple sclerosis. JAMA Neurol 74(5):574\u201382","journal-title":"JAMA Neurol"},{"issue":"1","key":"12866_CR42","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1177\/1352458517740214","volume":"25","author":"AM Pietroboni","year":"2019","unstructured":"Pietroboni AM, Dell\u2019Arti L, Caprioli M, Scarioni M, Carandini T, Arighi A et al (2019) The loss of macular ganglion cells begins from the early stages of disease and correlates with brain atrophy in multiple sclerosis patients. Mult Scler J 25(1):31\u20138","journal-title":"Mult Scler J"},{"issue":"11","key":"12866_CR43","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1093\/brain\/aww219","volume":"139","author":"B Knier","year":"2016","unstructured":"Knier B, Schmidt P, Aly L, Buck D, Berthele A, M\u00fchlau M et al (2016) Retinal inner nuclear layer volume reflects response to immunotherapy in multiple sclerosis. Brain 139(11):2855\u201363","journal-title":"Brain"},{"issue":"6","key":"12866_CR44","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1093\/brain\/awq080","volume":"133","author":"AJ Green","year":"2010","unstructured":"Green AJ, McQuaid S, Hauser SL, Allen IV, Lyness R (2010) Ocular pathology in multiple sclerosis: retinal atrophy and inflammation irrespective of disease duration. Brain 133(6):1591\u2013601","journal-title":"Brain"},{"issue":"10","key":"12866_CR45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0078341","volume":"8","author":"M Kaushik","year":"2013","unstructured":"Kaushik M, Wang CY, Barnett MH, Garrick R, Parratt J, Graham SL et al (2013) Inner nuclear layer thickening is inversley proportional to retinal ganglion cell loss in optic neuritis. PLoS ONE 8(10):e78341","journal-title":"PLoS ONE"},{"issue":"7","key":"12866_CR46","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1177\/1352458515604496","volume":"22","author":"B Knier","year":"2016","unstructured":"Knier B, Berthele A, Buck D, Schmidt P, Zimmer C, M\u00fchlau M et al (2016) Optical coherence tomography indicates disease activity prior to clinical onset of central nervous system demyelination. Mult Scler J 22(7):893\u2013900","journal-title":"Mult Scler J"},{"issue":"6","key":"12866_CR47","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1093\/brain\/aws098","volume":"135","author":"JM Gelfand","year":"2012","unstructured":"Gelfand JM, Nolan R, Schwartz DM, Graves J, Green AJ (2012) Microcystic macular oedema in multiple sclerosis is associated with disease severity. Brain 135(6):1786\u201393","journal-title":"Brain"},{"issue":"6","key":"12866_CR48","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/S1474-4422(16)00068-5","volume":"15","author":"EH Martinez-Lapiscina","year":"2016","unstructured":"Martinez-Lapiscina EH, Arnow S, Wilson JA, Saidha S, Preiningerova JL, Oberwahrenbrock T et al (2016) Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study. Lancet Neurol 15(6):574\u201384","journal-title":"Lancet Neurol"},{"issue":"2","key":"12866_CR49","doi-asserted-by":"crossref","first-page":"606","DOI":"10.3390\/biomedicines11020606","volume":"11","author":"VE Tiu","year":"2023","unstructured":"Tiu VE, Popescu BO, Enache II, Tiu C, Cherecheanu AP, Panea CA (2023) Serum Neurofilaments and OCT metrics predict EDSS-plus score progression in early relapse-remitting multiple sclerosis. Biomedicines 11(2):606","journal-title":"Biomedicines"},{"issue":"13","key":"12866_CR50","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1177\/1352458517729463","volume":"24","author":"R Lanzillo","year":"2018","unstructured":"Lanzillo R, Cennamo G, Criscuolo C, Carotenuto A, Velotti N, Sparnelli F et al (2018) Optical coherence tomography angiography retinal vascular network assessment in multiple sclerosis. Mult Scler J 24(13):1706\u201314","journal-title":"Mult Scler J"},{"key":"12866_CR51","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1007\/s10072-020-04431-4","volume":"41","author":"AM Pietroboni","year":"2020","unstructured":"Pietroboni AM, Carandini T, Dell\u2019Arti L, Bovis F, Colombi A, De Riz MA et al (2020) Evidence of retinal anterograde neurodegeneration in the very early stages of multiple sclerosis: a longitudinal OCT study. Neurol Sci 41:3175\u201383","journal-title":"Neurol Sci"},{"issue":"1","key":"12866_CR52","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1212\/WNL.0b013e31827b1a1c","volume":"80","author":"JN Ratchford","year":"2013","unstructured":"Ratchford JN, Saidha S, Sotirchos ES, Oh JA, Seigo MA, Eckstein C et al (2013) Active MS is associated with accelerated retinal ganglion cell\/inner plexiform layer thinning. Neurology 80(1):47\u201354","journal-title":"Neurology"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-024-12866-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-024-12866-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-024-12866-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T11:41:38Z","timestamp":1739619698000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-024-12866-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,15]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["12866"],"URL":"https:\/\/doi.org\/10.1007\/s00415-024-12866-4","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,15]]},"assertion":[{"value":"9 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Omid Mirmosayyeb and Dejan Jakimovski have nothing to disclose. Bianca Weinstock-Guttman received honoraria as a speaker and\/or as a consultant for Biogen Idec, Teva Pharmaceuticals, EMD Serono, Genzyme, Sanofi, Genentech, Novartis, Celgene\/BMS, Janssen and Horizon Dr Weinstock-Guttman received research funds from Biogen Idec, EMD Serono, Genzyme, Genentech, Sanofi, Novartis. Robert Zivadinov has received personal compensation from Bristol Myers Squibb, EMD Serono, Sanofi, Protembis, Janssen, 415 Capital, and Novartis for speaking and consultant fees. He received financial support for research activities from Sanofi, Novartis, Bristol Myers Squibb, Octave, Mapi Pharma, CorEvitas, Protembis and V-WAVE Medical.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}],"article-number":"141"}}